Modest Weight Loss Plus Few GI Upsets With Amylin Injectable

(MedPage Today) -- NEW ORLEANS--Petrelintide, an investigational long-acting amylin analog, induced significant weight loss with minimal side effects in the global phase II ZUPREME-1 study.
By week 28, all five investigational doses of petrelintide...